Page last updated: 2024-08-24

imiquimod and ribavirin

imiquimod has been researched along with ribavirin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Blatt, LM; Day, CW; Julander, JG; Morrey, JD; Sidwell, RW; Smee, DF1
Aoki, Y; Hiramine, S; Imamura, M; Ito, K; Kanto, T; Kimura, T; Kirikae, I; Korenaga, M; Masaki, N; Matsui, T; Mizokami, M; Murata, K; Saito, H; Sugiyama, M; Yoshio, S1

Other Studies

4 other study(ies) available for imiquimod and ribavirin

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models.
    Antiviral chemistry & chemotherapy, 2004, Volume: 15, Issue:2

    Topics: Aminoquinolines; Animals; Cells, Cultured; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Imiquimod; Interferon Inducers; Interferon Type I; Interferon-alpha; Interferons; Mice; Mice, Inbred BALB C; Motor Activity; Poly I-C; Poly U; Recombinant Proteins; Ribavirin; Survival Rate; Time Factors; West Nile Fever; West Nile virus

2004
Ex vivo induction of IFN-λ3 by a TLR7 agonist determines response to Peg-IFN/ribavirin therapy in chronic hepatitis C patients.
    Journal of gastroenterology, 2014, Volume: 49, Issue:1

    Topics: Aged; Aminoquinolines; Antiviral Agents; Cells, Cultured; Dendritic Cells; Drug Therapy, Combination; Female; Genotype; Hepatitis C, Chronic; Humans; Imiquimod; Interferon-alpha; Interferons; Interleukins; Leukocytes, Mononuclear; Male; Middle Aged; Polymorphism, Single Nucleotide; Prognosis; Ribavirin; RNA, Messenger; Toll-Like Receptor 7; Treatment Outcome

2014